|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang Y, Shi J, Huang H, Ren J, Li N and
Dai M: Burden of colorectal cancer in China. Zhonghua Liu Xing Bing
Xue Za Zhi. 36:709–914. 2015.(In Chinese). PubMed/NCBI
|
|
3
|
Chen X, Guo X, Zhang H, Xiang Y, Chen J,
Yin Y, Cai X, Wang K, Wang G, Ba Y, et al: Role of miR-143
targeting KRAS in colorectal tumorigenesis. Oncogene. 28:1385–1392.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mendell JT and Olson EN: MicroRNAs in
stress signaling and human disease. Cell. 148:1172–1187. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yamakuchi M, Ferlito M and Lowenstein CJ:
miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci
USA. 105:13421–13426. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bommer GT, Gerin I, Feng Y, Kaczorowski
AJ, Kuick R, Love RE, Zhai Y, Giordano TJ, Qin ZS, Moore BB, et al:
p53-mediated activation of miRNA34 candidate tumor-suppressor
genes. Curr Biol. 17:1298–1307. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xue G, Yan HL, Zhang Y, Hao LQ, Zhu XT,
Mei Q and Sun SH: c-Myc-mediated repression of miR-15-16 in hypoxia
is induced by increased HIF-2α and promotes tumor angiogenesis and
metastasis by upregulating FGF2. Oncogene. 34:1393–1406. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bracken CP, Gregory PA, Kolesnikoff N,
Bert AG, Wang J, Shannon MF and Goodall GJ: A double-negative
feedback loop between ZEB1-SIP1 and the microRNA-200 family
regulates epithelial-mesenchymal transition. Cancer Res.
68:7846–7854. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang DD, Chen X, Yu DD, Yang SJ, Shen HY,
Sha HH, Zhong SL, Zhao JH and Tang JH: miR-197: A novel biomarker
for cancers. Gene. 591:313–319. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hamada S, Satoh K, Miura S, Hirota M,
Kanno A, Masamune A, Kikuta K, Kume K, Unno J, Egawa S, et al:
MiR-197 induces epithelial-mesenchymal transition in pancreatic
cancer cells by targeting p120 catenin. J Cell Physiol.
228:1255–1263. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu L, Hou Y, Tu G, Chen Y, Du YE, Zhang H,
Wen S, Tang X, Yin J, Lang L, et al: Nuclear Drosha enhances cell
invasion via an EGFR-ERK1/2-MMP7 signaling pathway induced by
dysregulated miRNA-622/197 and their targets LAMC2 and
CD82 in gastric cancer. Cell Death Dis. 8:e26422017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dai W, Wang C, Wang F, Wang Y, Shen M,
Chen K, Cheng P, Zhang Y, Yang J, Zhu R, et al: Anti-miR-197
inhibits migration in HCC cells by targeting KAI 1/CD82. Biochem
Biophys Res Commun. 446:541–548. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun Z, Zhou N, Han Q, Zhao L, Bai C, Chen
Y, Zhou J and Zhao RC: MicroRNA-197 influences 5-fluorouracil
resistance via thymidylate synthase in colorectal cancer. Clin
Transl Oncol. 17:876–883. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun Z, Han Q, Zhou N, Wang S, Lu S, Bai C
and Zhao RC: Micro RNA-9 enhances migration and invasion through
KLF17 in hepatocellular carcinoma. Mol Oncol. 7:884–894. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fiori ME, Barbini C, Haas TL, Marroncelli
N, Patrizii M, Biffoni M and De Maria R: Antitumor effect of
miR-197 targeting in p53 wild-type lung cancer. Cell Death Differ.
21:774–782. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang Y, Li F, Saha MN, Abdi J, Qiu L and
Chang H: miR-137 and miR-197 induce apoptosis and suppress
tumorigenicity by targeting MCL-1 in multiple myeloma. Clin Cancer
Res. 21:2399–2411. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tian LQ, Liu EQ, Zhu XD, Wang XG, Li J and
Xu GM: MicroRNA-197 inhibits cell proliferation by targeting GAB2
in glioblastoma. Mol Med Rep. 13:4279–4288. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mavridis K, Gueugnon F, Petit-Courty A,
Courty Y, Barascu A, Guyetant S and Scorilas A: The oncomiR miR-197
is a novel prognostic indicator for non-small cell lung cancer
patients. Br J Cancer. 112:1527–1535. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang R, Wen H, Xu Y, Chen Q, Luo Y, Lin Y,
Luo Y and Xu A: Circulating microRNAs as a novel class of
diagnostic biomarkers in gastrointestinal tumors detection: A
meta-analysis based on 42 articles. PLoS One. 9:e1134012014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu M, Kuang Y, Wang M, Han X and Yang Q: A
microRNA expression signature as a predictor of survival for colon
adenocarcinoma. Neoplasma. 64:56–64. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Firth SM and Baxter RC: Cellular actions
of the insulin-like growth factor binding proteins. Endocr Rev.
23:824–854. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li H, Batth IS, Qu X, Xu L, Song N, Wang R
and Liu Y: IGF-IR signaling in epithelial to mesenchymal transition
and targeting IGF-IR therapy: Overview and new insights. Mol
Cancer. 16:62017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yao C, Su L, Shan J, Zhu C, Liu L, Liu C,
Xu Y, Yang Z, Bian X, Shao J, et al: IGF/STAT3/NANOG/Slug signaling
axis simultaneously controls epithelial-mesenchymal transition and
stemness maintenance in colorectal cancer. Stem Cells. 34:820–831.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee HJ, Lee JS, Hwang SJ and Lee HY:
Insulin-like growth factor binding protein-3 inhibits cell adhesion
via suppression of integrin β4 expression. Oncotarget.
6:15150–15163. 2015.PubMed/NCBI
|
|
26
|
Han J, Jogie-Brahim S, Harada A and Oh Y:
Insulin-like growth factor-binding protein-3 suppresses tumor
growth via activation of caspase-dependent apoptosis and cross-talk
with NF-κB signaling. Cancer Lett. 307:200–210. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Buckbinder L, Talbott R, Velasco-Miguel S,
Takenaka I, Faha B, Seizinger BR and Kley N: Induction of the
growth inhibitor IGF-binding protein 3 by p53. Nature. 377:646–649.
1995. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zielinska HA, Bahl A, Holly JM and Perks
CM: Epithelial-to-mesenchymal transition in breast cancer: A role
for insulin-like growth factor I and insulin-like growth
factor-binding protein 3? Breast Cancer. 7:9–19. 2015.PubMed/NCBI
|
|
29
|
Yang CH, Yue J, Pfeffer SR, Fan M, Paulus
E, Hosni-Ahmed A, Sims M, Qayyum S, Davidoff AM, Handorf CR and
Pfeffer LM: MicroRNA-21 promotes glioblastoma tumorigenesis by
down-regulating insulin-like growth factor-binding protein-3
(IGFBP3). J Biol Chem. 289:25079–25087. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
El Tayebi HM, Waly AA, Assal RA, Hosny KA,
Esmat G and Abdelaziz AI: Transcriptional activation of the
IGF-II/IGF-1R axis and inhibition of IGFBP-3 by miR-155 in
hepatocellular carcinoma. Oncol Lett. 10:3206–3212. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang HH, Wang YC, Wu DW, Hung CS, Chen CY
and Lee H: Targeting insulin-like growth factor-binding protein-3
by microRNA-125b promotes tumor invasion and poor outcomes in
non-small-cell lung cancer. Tumour Biol.
39:10104283176943162017.PubMed/NCBI
|
|
32
|
Xiong B, Cheng Y, Ma L and Zhang C: MiR-21
regulates biological behavior thourgh the PTEN/PI-3K/Akt signalling
pathway in human colorectal cancer cells. Int J Oncol. 42:219–228.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Iwakawa HO and Tomari Y: The functions of
microRNAs: mRNA decay and translational respression. Trends Cell
Biol. 25:651–665. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kundu P, Fabian M, Sonenberg N,
Bhattacharyya SN and Filipowicz W: HuR protein attenuates
miRNA-mediated repression by promoting miRISC dissociation from the
target RNA. Nucleic Acids Res. 40:5088–5100. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Haydon AM, Macinnis RJ, English DR, Morris
H and Giles GG: Physical activity, insulin-like growth factor 1,
insulin-like growth factor binding protein 3, and survival from
colorectal cancer. Gut. 55:689–694. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fu T, Pappou EP, Guzzetta AA, Mde Calmon
F, Sun L, Herrera A, Li F, Wolfgang CL, Baylin SB,
Iacobuzio-Donahue CA, et al: IGFBP-3 gene methylation in
primary tumor predicts recurrence of stage II colorectal cancers.
Ann Surg. 263:337–344. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Perez-Carbonell L, Balaguer F, Toiyama Y,
Egoavil C, Rojas E, Guarinos C, Andreu M, Llor X, Castells A, Jover
R, et al: IGFBP3 methylation is a novel diagnostic and
predictive biomarker in colorectal cancer. PLoS One. 9:e1042852014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wolpin BM, Meyerhardt JA, Chan AT, Ng K,
Chan JA, Wu K, Pollak MN, Giovannucci EL and Fuchs CS: Insulin, the
insulin-like growth factor axis, and mortality in patients with
nonmetastatic colorectal cancer. J Clin Oncol. 27:176–185. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xue M, Fang Y, Sun G, Zhuo W, Zhong J,
Qian C, Wang L, Wang L, Si J and Chen S: IGFBP3, a transcriptional
target of homeobox D10, is correlated with the prognosis of gastric
cancer. PLoS One. 8:e814232013. View Article : Google Scholar : PubMed/NCBI
|
